H2-D1 Antikörper (FITC)
Kurzübersicht für H2-D1 Antikörper (FITC) (ABIN135413)
Target
Alle H2-D1 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Spezifität
- Mouse H-2Db
-
Produktmerkmale
- Mouse Anti-Mouse H-2Db-FITC
-
Immunogen
- C3H.SW mouse splenocytes
-
Isotyp
- IgG2a
-
-
-
-
Applikationshinweise
-
- Applications: FC - Quality tested , IHC-FS - Reported in literature , IP - Reported in literature , Block - Reported in literature , CMCD - Reported in literature
- Working Dilutions: Flow Cytometry Purified (UNLB) antibody 1 g/106 cells FITC, BIOT, and AF488 conjugates 1 g/106 cells PE conjugate 0.5 g/106 cells APC conjugate 0.1 g/106 cells For flow cytometry, the suggested use of these reagents is in a final volume of 100 L
-
Kommentare
-
Complement-mediated cytotoxicity
-
Probenmenge
- 1 mL
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Konzentration
- 0.5 mg/mL
-
Buffer
- 0.5 mg in 1.0 mL of PBS/Sodium azide
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
-
Protect conjugated products from light.
Each reagent is stable for the period shown on the bottle label if stored as directed. -
Lagerung
- 4 °C
-
Informationen zur Lagerung
- Store at 2-8°C
-
-
- H2-D1 (Histocompatibility 2, D Region Locus 1 (H2-D1))
-
Andere Bezeichnung
- H-2Db
-
Hintergrund
- The classical MHC Class I molecules are histocompatibility antigens encoded by the H-2 gene complex and consist of heterodimers of highly polymorphic chains noncovalently associated with the invariant 2-microglobulin. These antigens are expressed on most nucleated cells but expression varies on different cell types. MHC Class I molecules present endogenously synthesized peptides to CD8+ T lymphocytes, which are usually cytotoxic T cells.5 MHC Class I antigens expressed on thymic epithelial cells regulate the positive and negative selection of CD8+ T cells during T cell ontogeny.
-
Pathways
- Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process
Target
-